KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenon Pharmaceuticals (XENE) Asset Utilization Ratio: 2014-2025

Historic Asset Utilization Ratio for Xenon Pharmaceuticals (XENE) over the last 8 years, with Mar 2025 value amounting to 0.02.

  • Xenon Pharmaceuticals' Asset Utilization Ratio was N/A to 0.02 in Q1 2025 from the same period last year, while for Mar 2025 it was 0.02, marking a year-over-year change of. This contributed to the annual value of 0.01 for FY2022, which is 70.63% down from last year.
  • Xenon Pharmaceuticals' Asset Utilization Ratio amounted to 0.02 in Q1 2025, which was up 32.05% from 0.02 recorded in Q3 2022.
  • Xenon Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.12 for Q1 2021, and its period low was 0.02 during Q3 2022.
  • Over the past 1 years, Xenon Pharmaceuticals' median Asset Utilization Ratio value was 0.02 (recorded in 2025), while the average stood at 0.02.
  • Examining YoY changes over the last 5 years, Xenon Pharmaceuticals' Asset Utilization Ratio showed a top increase of 74.34% in 2021 and a maximum decrease of 78.62% in 2021.
  • Quarterly analysis of 3 years shows Xenon Pharmaceuticals' Asset Utilization Ratio stood at 0.04 in 2021, then tumbled by 72.36% to 0.02 in 2022, then reached 0.02 in 2025.
  • Its Asset Utilization Ratio stands at 0.02 for Q1 2025, versus 0.02 for Q3 2022 and 0.03 for Q2 2022.